Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1244765.RAzzmSYjYoeqhDm99Upb3sBc_ypb-cl1WeX_Be89ZtunM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1244765.RAzzmSYjYoeqhDm99Upb3sBc_ypb-cl1WeX_Be89ZtunM130_assertion type Assertion NP1244765.RAzzmSYjYoeqhDm99Upb3sBc_ypb-cl1WeX_Be89ZtunM130_head.
- NP1244765.RAzzmSYjYoeqhDm99Upb3sBc_ypb-cl1WeX_Be89ZtunM130_assertion description "[MBL-II-141 strongly increased CPT-11 levels in the brain, and therefore would be a valuable agent to improve drug distribution into the brain to efficiently treat aggressive gliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1244765.RAzzmSYjYoeqhDm99Upb3sBc_ypb-cl1WeX_Be89ZtunM130_provenance.
- NP1244765.RAzzmSYjYoeqhDm99Upb3sBc_ypb-cl1WeX_Be89ZtunM130_assertion evidence source_evidence_literature NP1244765.RAzzmSYjYoeqhDm99Upb3sBc_ypb-cl1WeX_Be89ZtunM130_provenance.
- NP1244765.RAzzmSYjYoeqhDm99Upb3sBc_ypb-cl1WeX_Be89ZtunM130_assertion SIO_000772 25474134 NP1244765.RAzzmSYjYoeqhDm99Upb3sBc_ypb-cl1WeX_Be89ZtunM130_provenance.
- NP1244765.RAzzmSYjYoeqhDm99Upb3sBc_ypb-cl1WeX_Be89ZtunM130_assertion wasDerivedFrom befree-2016 NP1244765.RAzzmSYjYoeqhDm99Upb3sBc_ypb-cl1WeX_Be89ZtunM130_provenance.
- NP1244765.RAzzmSYjYoeqhDm99Upb3sBc_ypb-cl1WeX_Be89ZtunM130_assertion wasGeneratedBy ECO_0000203 NP1244765.RAzzmSYjYoeqhDm99Upb3sBc_ypb-cl1WeX_Be89ZtunM130_provenance.